Sullivan Christopher Ryan
Chief Financial Officer
CIK: 1810417
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 7, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 18,606 | $24.12 | $448,817.65 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 12,347 | $19.28 | $238,093.37 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 2,700 | $20.76 | $56,052.00 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 8,900 | $22.57 | $200,913.05 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 13,834 | $18.55 | $256,655.28 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 9,219 | $21.37 | $197,008.19 | View Details Filing |
| Apr 30, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 8,457 | $13.23 | $111,853.13 | View Details Filing |
| Apr 29, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 8,458 | $13.09 | $110,736.36 | View Details Filing |